Science
Iterum Therapeutics Plc (NASDAQ:ITRM) Has Seen A Fall Of -42.94% This Year, Is It Still A Better Option Than Others?
In last trading session, Iterum Therapeutics Plc (NASDAQ:ITRM) saw 0.42 million shares changing hands with its beta currently measuring 2.81. Company’s recent per share price